Researchers have carried out the first investigation of how obesity affects Alzheimer’s disease blood biomarkers (BBMs). In this work, BBM levels rose up to 95% more quickly in people with obesity than in people without obesity, based on findings presented at the annual meeting of the Radiological Society of North America (RSNA).
Obesity adn Alzheimer’s Disease: A Growing Concern
Table of Contents
A new study reveals a significant link between obesity and the progression of Alzheimer’s disease, as measured by blood biomarkers. This research, presented at the Radiological Society of North America (RSNA) annual meeting, demonstrates that individuals with obesity experiance a faster rate of change in Alzheimer’s disease blood biomarkers compared to those without obesity.
first-of-its-Kind Investigation
“This is the first time we’ve shown the relationship between obesity and Alzheimer’s disease as measured by blood biomarker tests,” saeid Cyrus Raji, M.D., Ph.D., senior author of the study and a principal investigator in the Neuroimaging Labs Research Center at Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis.
Long-Term Brain imaging and Blood Data
The study leveraged five years of data from 407 volunteers participating in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Researchers analyzed longitudinal data, combining brain imaging with blood biomarker measurements to understand how obesity influences the biological changes associated with Alzheimer’s disease.
Key Findings: Accelerated Biomarker Progression
The research team found that individuals with obesity exhibited a significantly faster rate of increase in Alzheimer’s disease blood biomarkers. Specifically, BBM levels increased up to 95% more rapidly in obese participants compared to their non-obese counterparts. These biomarkers include:
- p-tau181: A marker of tau protein, which forms tangles in the brains of people with Alzheimer’s.
- Aβ42/Aβ40: A ratio reflecting amyloid beta protein levels, another hallmark of Alzheimer’s disease.
These findings suggest that obesity may accelerate the underlying pathological processes of Alzheimer’s disease, even before noticeable cognitive decline.
Why Does Obesity Matter in Alzheimer’s?
The connection between obesity and Alzheimer’s disease is complex and likely involves several factors. Obesity is frequently enough associated with:
- Chronic Inflammation: Excess body fat can trigger chronic, low-grade inflammation throughout the body, including the brain. Inflammation is increasingly recognized as a key contributor to neurodegenerative diseases like Alzheimer’s.
- insulin Resistance: Obesity frequently leads to insulin resistance, where the body’s cells don’t respond effectively to insulin. The brain relies on insulin for energy, and insulin resistance can impair brain function.
- Vascular Damage: Obesity increases the risk of cardiovascular disease, which can damage blood vessels in the brain and contribute to cognitive decline.
Implications and Future Research
This study highlights the importance of addressing obesity as a potential modifiable risk factor for Alzheimer’s disease. Maintaining a healthy weight through diet and exercise may help slow the progression of the disease. Further research is needed to fully understand the mechanisms linking obesity and Alzheimer’s, and to develop targeted interventions.
Key Takeaways
- Obesity is linked to a faster rate of progression of Alzheimer’s disease biomarkers.
- BBM levels increased up to 95% more quickly in obese individuals.
- Chronic inflammation, insulin resistance, and vascular damage may explain this connection.
- Maintaining a healthy weight could be a strategy to reduce Alzheimer’s risk.
Keep reading